A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis

• Main Authors: Elmira Karami (Author), Jean-Marc Sabatier (Author), Mahdi Behdani (Author), Shiva Irani (Author), Fatemeh Kazemi-Lomedasht (Author)
• Format: Book
• Published: Taylor & Francis Group, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Vascular Endothelial Growth Factor (VEGF) promotes angiogenesis in tumours of various cancers. Monoclonal antibodies and nanobodies are one of the potent agents in the treatment of cancer. Due to their high costs, researchers are considering to design and produce peptides as a substitute approach in...